Reference
1. Bearpark L, Sartipy U, Franco-Cereceda A, Glaser N. Surgery for Endocarditis in Intravenous Drug Users. Ann Thorac Surg . 2021;112(2):573-581. doi:10.1016/j.athoracsur.2020.09.013
2. Nguemeni Tiako MJ, Mori M, Bin Mahmood SU, et al. Recidivism Is the Leading Cause of Death Among Intravenous Drug Users Who Underwent Cardiac Surgery for Infective Endocarditis. Semin Thorac Cardiovasc Surg . 2019;31(1):40-45. doi:10.1053/j.semtcvs.2018.07.016
3. Shmueli H, Thomas F, Flint N, Setia G, Janjic A, Siegel RJ. Right‐Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment. J Am Heart Assoc . 2020;9(15):e017293. doi:10.1161/JAHA.120.017293
4. Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: An analysis of the Society of Thoracic Surgeons national database. J Thorac Cardiovasc Surg . 2021;161(4):1227-1235.e1. doi:10.1016/j.jtcvs.2019.10.124
5. Luc JGY, Choi JH, Kodia K, et al. Valvectomy versus replacement for the surgical treatment of infective tricuspid valve endocarditis: a systematic review and meta-analysis. Ann Cardiothorac Surg . 2019;8(6):610-620. doi:10.21037/acs.2019.11.06
6. Macedo J, Grawe ES. Hypoxemia Requiring Venovenous Extracorporeal Membrane Oxygenation after Tricuspid Valvulectomy for Infective Endocarditis. CASE . 2019;3(4):183-186. doi:10.1016/j.case.2019.04.002
7. Hull SC, Jadbabaie F. When Is Enough Enough? The Dilemma of Valve Replacement in a Recidivist Intravenous Drug User. Ann Thorac Surg . 2014;97(5):1486-1487. doi:10.1016/j.athoracsur.2014.02.010
8. Elbatarny M, Bahji A, Bisleri G, Hamilton A. Management of endocarditis among persons who inject drugs: A narrative review of surgical and psychiatric approaches and controversies. Gen Hosp Psychiatry . 2019;57:44-49. doi:10.1016/j.genhosppsych.2019.01.008